First of its kind diagnostic center opens in Uganda with lifesaving equipment: GE Healthcare & AFRIPHARMA partner to serve communities



GE Healthcare ( (NYSE: GEHC) and medical group AFRIPHARMA announce the opening of the Afri-Egypt Health Services Center, a first of its kind in Uganda with lifesaving equipment from GE Healthcare. The Center is located in Jinja and is expected to serve to over 60,000 people from the region, allowing for improved accessibility in the surrounding communities.

The facility is equipped with GE equipment including CT Scan Machine, Digital Mammography, X-ray, BMD, Ultrasound, and Life Care solutions. These technology is used in the diagnosis and treatment of various critical diseases, including in the areas of women’s heath, neonatal care, cardiology, internal medicine, HIV, infectious diseases, and COVID-19.

This is a regional project between GE Healthcare and AFRIPHARMA which brought global partners together to develop the strategy, design, and execution of the facility, including the operations and processes, with one goal in mind: better patient care in Uganda, East Africa and Sub-Saharan Africa.

Professor Madiha Khattab, CEO AFRIPHARMA said “This state-of-the-art Health Facility was built to very high standards with the patients in mind despite the challenging environment of the COVID pandemic, with the partners determined to bring domestic treatment to Ugandans and help improve lives”.

Jennifer Kinyoe, General Manager, GE Healthcare East Africa said, “GE Healthcare has been a partner in the region for many decades, through both good and challenging times. This project is a great example of how global partners and institutions can support critical local needs in Uganda. Through this innovative facility, access across the entire country is improved, we support clinicians to have early diagnosis and lives will be saved. This supports our strategy in Africa to bring the best healthcare services right to the patients, helping doctors and practitioners to diagnose, treat, and save lives.” 

Distributed by APO Group on behalf of GE.

About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases